Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration r omized controlled trial r omized r omised ab ti placebo ab ti dt r omly ab ti trial ab ti groups ab ti animals humans macular degeneration retinal degeneration retinal neovascularization ch oidal neovascularization macula lutea maculopath macul retina ch oid degener macul retina ch oid neovasc macula lutea AMD ARMD CNV angiogenesis inhibit s angiogenesis inducing agents endothelial growth fact s vascular endothelial growth fact s anti VEGF endothelial growth fact anti adj angiogen macugen pegaptanib lucentis rhufab ranibizumab bevacizumab avastin aflibercept conbercept VEGF TRAP limit to ED specif gradi m.maier@irz.tum.d giovanna consolid drgokcengokce@gmail.com uoc ought baril henri biologia water likewis myocardi d'amato yoshimi rank watersh danb@clalit.org.il yang
